Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Occidental Petroleum
OXY
|
+$634M |
| 2 |
CVS Health
CVS
|
+$597M |
| 3 |
3M
MMM
|
+$504M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$443M |
| 5 |
Kraft Heinz
KHC
|
+$397M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sempra
SRE
|
+$667M |
| 2 |
Merck
MRK
|
+$510M |
| 3 |
DuPont de Nemours
DD
|
+$487M |
| 4 |
UBS Group
UBS
|
+$482M |
| 5 |
Cummins
CMI
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.15% |
| 2 | Technology | 15.86% |
| 3 | Financials | 14.28% |
| 4 | Industrials | 9.17% |
| 5 | Communication Services | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
701
Crescent Biopharma
CBIO
$602M
| $20.5M | 0.01% |
17,188
-419
| -2% | -$501K |
|
|
ALTR
702
DELISTED
Altair Engineering Inc
ALTR
| $20.5M | 0.01% |
506,484
+234
| +0% | +$8.75K |
|
703
General Mills
GIS
$19.2B
| $20.2M | 0.01% |
384,160
-121,853
| -24% | -$6.3M |
|
704
Bio-Rad Laboratories Class A
BIO
$8.42B
| $20.2M | 0.01% |
64,528
+12,800
| +25% | +$3.83M |
|
705
Gran Tierra Energy
GTE
$260M
| $20.1M | 0.01% |
1,283,982
-38,151
| -3% | -$813K |
|
706
Alexandria Real Estate Equities
ARE
$8.88B
| $20.1M | 0.01% |
142,505
-15,355
| -10% | -$2.22M |
|
707
Evercore
EVR
$13.1B
| $20.1M | 0.01% |
226,459
+2,660
| +1% | +$237K |
|
708
Acadia Pharmaceuticals
ACAD
$4.25B
| $20M | 0.01% |
749,790
| – | – |
|
709
CRISPR Therapeutics
CRSP
$4.58B
| $20M | 0.01% |
424,613
| – | – |
|
710
Healthpeak Properties
DOC
$15.4B
| $19.9M | 0.01% |
622,447
-11,205
| -2% | -$348K |
|
711
Brookfield Infrastructure Partners
BIP
$18.8B
| $19.9M | 0.01% |
778,152
-102,480
| -12% | -$2.55M |
|
|
NVO
712
Novo Nordisk
NVO
$216B
| $19.3M | 0.01% |
756,826
-72,084
| -9% | -$1.78M |
|
713
New Oriental
EDU
$7.84B
| $19.3M | 0.01% |
199,350
+186,322
| +1,430% | +$16.7M |
|
|
MRSH
714
Marsh
MRSH
$86.3B
| $19.1M | 0.01% |
191,386
+40,261
| +27% | +$3.85M |
|
715
Ares Management
ARES
$28.5B
| $18.9M | 0.01% |
+724,000
| New | +$18.4M |
|
716
Las Vegas Sands
LVS
$30.5B
| $18.9M | 0.01% |
320,325
-40,482
| -11% | -$2.51M |
|
717
Neogen
NEOG
$2.05B
| $18.9M | 0.01% |
609,356
-58
| -0% | -$1.71K |
|
|
BLUE
718
DELISTED
bluebird bio
BLUE
| $18.9M | 0.01% |
11,480
| – | – |
|
719
Emergent Biosolutions
EBS
$375M
| $18.8M | 0.01% |
389,534
+182,197
| +88% | +$8.73M |
|
720
Xencor
XNCR
$1.44B
| $18.7M | 0.01% |
457,432
| – | – |
|
|
DFS
721
DELISTED
Discover Financial Services
DFS
| $18.7M | 0.01% |
240,612
+74,475
| +45% | +$5.77M |
|
722
Simpson Manufacturing
SSD
$7.98B
| $18.5M | 0.01% |
278,638
-55,979
| -17% | -$3.58M |
|
|
BPY
723
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $18.4M | 0.01% |
971,752
-25,073
| -3% | -$500K |
|
|
GSS
724
DELISTED
Golden Star Resources Ltd.
GSS
| $18.3M | 0.01% |
4,538,333
-85,000
| -2% | -$332K |
|
725
Incyte
INCY
$23.5B
| $18.3M | 0.01% |
215,134
-20,347
| -9% | -$1.63M |
|
Similar funds
Franklin Resources's Q2 2019 Portfolio in Review
As of Q2 2019, Franklin Resources held 1,620 positions worth $188B, up 0.7% from $187B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Franklin Resources withdrew a net $5.99B in Q2 2019, closing 78 positions and reducing 611 holdings. Its most notable exit was L3Harris, an estimated $48.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Franklin Resources opened a new position in Dow Inc worth $256M.
- Franklin Resources's largest Q2 2019 buy was Dow Inc: 5,190,536 shares worth $256M.
- Franklin Resources added most to Occidental Petroleum in Q2 2019, an estimated $634M increase.
- Franklin Resources's biggest Q2 2019 reduction was Sempra, cutting an estimated $667M.
- Franklin Resources fully exited L3Harris in Q2 2019, selling an estimated $48.7M.
- Franklin Resources's ten largest holdings make up 12% of its $188B portfolio in Q2 2019.
- Franklin Resources opened 134 new positions and closed 78 in Q2 2019.
- Franklin Resources's portfolio value rose 0.7% quarter-over-quarter to $188B.
Based on Franklin Resources's 13F filing for Q2 2019, filed 14 Aug 2019.